Stock Events

Stock Events

Cocrystal Pharma (8CC.F) Q2 2025 Earnings

15MayConfirmed

Q2 2024

Q3 2024

Q4 2024

Q2 2025

-0.54

-0.43

-0.32

-0.21

Details

Expected EPS

-0.45125790000000005

Actual EPS

-0.20552340000000002

Surprise EPS

0.25

Surprise Percent

+54.46%

Description

Cocrystal Pharma (8CC.F) has reported earnings of -0.20552340000000002 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.